Quicklinks >          Terms          |          Transition to Open          |          OA roadmap       

Read & Publish 

Uncapped Read & Publish 

Our uncapped Read & Publish (R&P) model ensures stability and budget predictability by covering all papers and article types and imposing no quota or limits requiring top-up fees. It addresses the needs of authors and institutions, making it easier than ever for researchers to publish with us and integrating reporting services for the benefit of librarians and information specialists. With guaranteed and unlimited open access (OA) publishing, R&P maximises the reach of published papers, driving the impact of research from across the molecular biosciences. For a single annual R&P fee, we offer participating institutions: 

• Unlimited Gold OA publishing for corresponding authors across all of our journals, ensuring funder compliance and without the need for any payment of article publishing charges; 
• Read access to all journals and their full archives, in perpetuity, across our portfolio; 
• Simple R&P workflow for authors: our editorial submission system has been updated to ensure that publishing in our journals means OA publishing, by default, for all affiliated corresponding authors; 
• Real-time reporting on agreements and publications for librarians through the RightsLink institutional portal. 

To take up a R&P licence or upgrade from a read-only subscription, contact our Sales team. 

To optimise an existing R&P licence for your institution, visit institutional support services to ensure you and your researchers are getting the fullest level of support and reporting that we offer. 

Read & Publish impact 

Read & Publish achieves tangible impacts over and above the benefits that OA publishing in and of itself brings: 

• Institutions which have signed up to R&P have increased returns on investment when measured by cost per download.

• R&P funding of OA has significantly boosted the proportion of OA content that has been published in our portfolio.
• With this alternative to author-funded OA, individual article transactions (article publishing charges) have decreased, relieving many researchers from the payment cycle.
• Helping to achieve our mission to promote greater equity and inclusivity, all researchers affiliated with our R&P cohort (whether grant funded or not) are immediately and by default eligible for fee-free OA. 

With three years of trial data, this 2023 case study provides the relative successes of increased OA publishing across our portfolio in three global regions. 

Read & Publish good practice 

• Society Publishers’ Coalition 
• OA Switchboard 
• CCC Rightslink 
• cOAlition S  
• SPA-OPS (funded by Wellcome, UKRI and ALPSP) with Information Power 
• Consortium partners: JISC, CAUL, MPDL, CSIC, CDL, JULAC, MALMAD, TIB German Alliance, Bibsam